Publication Author: Sullivan_Sean
-
An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis.
Carlson JJ, Kowdley KV, Sullivan SD, Ramsey SD, Veenstra DL. An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis. J Gastroenterol Hepatol. 2009 May;24(5):786-91. doi: 10.1111/
rakerr2
-
Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH. Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy. Value Health. 2009 Mar-Apr;12(2):21
rakerr2
-
The costs of change: direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003.
Levy AR, Sobolev B, James D, Barrable W, Clarke-Richardson P, Sullivan SD, Keown PA, Chung S, Straatman L, Levy RD. The costs of change: direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003. Value Health. 2009 Mar-Apr
rakerr2
-
The payer’s dilemma: recognizing the uncertainty of clinical and economic evidence at product launch.
Watkins JB, Sullivan SD. The payer’s dilemma: recognizing the uncertainty of clinical and economic evidence at product launch. J Manag Care Pharm. 2009 Mar;15(2):167-70.
rakerr2
-
Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone.
Sullivan SD, Alfonso-Cristancho R, Conner C, Hammer M, Blonde L. Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone. Cardiovasc Diabetol. 2009 Feb 26;8:12. doi: 10.1186/1475-2840-8-12.
rakerr2
-
The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery.
Blough DK, Ramsey S, Sullivan SD, Yusen R; Nett Research Group. The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery. Health Econ. 2009 Jan;18(1):9
rakerr2
-
Health economics of asthma: assessing the value of asthma interventions.
Campbell JD, Spackman DE, Sullivan SD. Health economics of asthma: assessing the value of asthma interventions. Allergy. 2008 Dec;63(12):1581-92. doi: 10.1111/j.1398-9995.2008.01888.x. Review.
rakerr2
-
Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD.
Najafzadeh M, Marra CA, Sadatsafavi M, Aaron SD, Sullivan SD, Vandemheen KL, Jones PW, Fitzgerald JM. Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD. Thorax. 2008 Nov;63(11):962-7.
rakerr2
-
The response to combination therapy treatment regimens in severe/difficult-to-treat asthma.
Campbell JD, Borish L, Haselkorn T, Rasouliyan L, Lee JH, Wenzel SE, Sullivan SD; TENOR Study Group. The response to combination therapy treatment regimens in severe/difficult-to-treat asthma. Eur Respir J. 2008 Nov;32(5):1237-42. doi: 10.1183/09031936.00
rakerr2
-
Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma.
Campbell JD, Blough DK, Sullivan SD. Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2008 Nov;101(5):474-81. doi: 10.1016/S1081-1206(10)60285-2.
rakerr2